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Abstract objectives Adolescents living with HIV face substantial difficulties in accessing HIV care services
and have worse treatment outcomes than other age groups. The objective of this review was to
evaluate the effectiveness of service delivery interventions to improve adolescents’ linkage from HIV
diagnosis to antiretroviral therapy (ART) initiation, retention in HIV care and adherence to ART.
methods We systematically searched the Medline, SCOPUS and Web of Sciences databases and
conference abstracts from the International AIDS Conference and International Conference on AIDS
and STIs in Africa (ICASA). Studies published in English between 1st January 2001 and 9th June
2014 were included. Two authors independently evaluated reports for eligibility, extracted data and
assessed methodological quality using the Cochrane risk of bias tool and Newcastle–Ottawa Scale.
results Eleven studies from nine countries were eligible for review. Three studies were randomised
controlled trials. Interventions assessed included individual and group counselling and education; peer
support; directly observed therapy; financial incentives; and interventions to improve the adolescent-
friendliness of clinics. Most studies were of low to moderate methodological quality.
conclusions This review identified limited evidence on the effectiveness of service delivery
interventions to support adolescents’ linkage from HIV diagnosis to ART initiation, retention on
ART and adherence to ART. Although recommendations are qualified because of the small numbers
of studies and limited methodological quality, offering individual and group education and
counselling, financial incentives, increasing clinic accessibility and provision of specific adolescent-
tailored services appear promising interventions and warrant further investigation.
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Introduction
An estimated 2.1 million adolescents (people aged
between 10 and 19 years old) are infected with HIV [1],
with the majority (85%) living in sub-Saharan Africa [1].
Adolescents are an underserved group in global and
national responses to the HIV epidemic [2, 3], and, to
date, global declarations, commitments and targets have
failed to address their specific needs [1]. Adolescents may
be infected with HIV through sexual contact or exposure
to unsafe injections (horizontal transmission); or in utero,
during delivery, or whilst breastfeeding as an infant (ver-
tically acquired) [4]. About one-third of infants who are
infected with HIV will survive into adolescence without
treatment [5]. This means that large numbers of infants
who were infected perinatally with HIV early in the epi-
demic before antiretroviral prevention of mother-to-child
transmission was widely available are now surviving in
adolescence due to increased availability of antiretroviral
therapy (ART).*Free full access from www.tmih.com
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Adolescents infected with HIV face particular chal-
lenges accessing effective care and achieving successful
treatment outcomes (Figure 1). Adolescents undergo a
period of rapid physical, emotional and behavioural
change [3]. They frequently face substantial socio-eco-
nomic problems, which may be accentuated if they are
orphaned or looked-after by social care services [11].
Adolescents who were infected with HIV perinatally may
have health and developmental problems including
opportunistic infections, stunting, chronic lung disease
and neuropsychiatric complications [2]. There is little
specific provision for adolescents within the health sys-
tems of most countries, with this group often falling into
the gaps between paediatric and adult services. Problems
related to the transition between paediatric and adult
care are common [3] and include adolescents’ fear of
leaving supportive paediatric care, competing demands
with higher education, starting employment and moving
out of the family home, and insufficient proactive transi-
tion planning by health services, all of which may con-
tribute to periods of worsened HIV care outcomes [6].
The few studies that have investigated HIV-infected
adolescents’ progression through the HIV care pathway
have generally found their outcomes to be poor and
worse than for adults or young children. Rates of reten-
tion in care prior to antiretroviral therapy (ART) initia-
tion have been reported to be substantially worse for
adolescents than for adults [7]. Once ART has been initi-
ated, retention [8] and adherence to treatment are also
poor, with a recent systematic review showing that,
although studies used different measurement approaches,
an average of only 62% of 12- to 24-year olds achieved
95% or greater adherence [9].
Interventions to ensure adolescents’ prompt linkage
into HIV care and high levels of retention and adherence
to ART could have substantial individual and public
health benefits [10–12], but must be responsive to their
unique needs. This study reviewed the effectiveness of
service delivery interventions aimed at improving adoles-
cents’ linkage into HIV care and their subsequent reten-
tion and adherence to ART.
Methods
Study design
Systematic review.
Inclusion and exclusion criteria
This review included studies published between 1st Janu-
ary 2001 and 9th June 2014. We sought studies that
reported on the effect of service delivery interventions on
adolescents’ linkage from HIV diagnosis to ART initia-
tion, retention on ART and adherence to ART. Both
randomised controlled trials and non-randomised studies
(cohort studies, case–control studies, before and after and
time-series studies, and reports of routinely collected pro-
gramme data) were included. Reviews, commentaries,
editorials, case studies, case series, economic analyses,
mathematical modelling studies and qualitative studies
were excluded.
Adolescents were defined as study participants aged
between 10 and 19 years. Studies were included if the
majority (>50%) of study participants were adolescents.
Studies that reported on mixed cohorts (young adults and
adolescents, or older children and adolescents) were
included if the mean or median age of the participants
was between 10 and 19 years of age, or if the majority
(>50%) of participants were aged between 10 and
19 years. In other studies, where the effect of interven-
tions on participants with a wider range of ages was
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Figure 1 The adolescent-focused HIV care pathway. Based on a figure by Kranzer and colleagues [79] (adapted).
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investigated, we included studies where age-disaggregated
data relevant to adolescents were reported.
Service delivery interventions [13] were defined to be
interventions provided through health systems or health
providers with the objective of improving adolescents’
linkage from HIV diagnosis to ART initiation, retention
on ART or adherence to ART. Studies that reported
exclusively on the effect of one or more specific clinical
treatment options (such as specific ART regimens or com-
binations) were excluded.
Completion of steps on the HIV care pathway between
HIV diagnosis and initiation of ART was defined to
include any of completion of assessment of ART eligibility
(clinical staging, CD4 count measurement); completion of
educational sessions and training; continuous collection of
prophylactic therapy; and initiation of ART. In line with
WHO recommendations on terminology [14], we defined
retention on ART as continuous engagement in ART treat-
ment, with retained participants being adolescents who
attended at least one scheduled treatment appointment
within the last 90 days. Adherence to ART was defined as
regularly taking all antiretroviral medications that made
up the prescribed ART regimen in the correct dose and at
the correct time. Studies used a variety of outcome mea-
sures to define these outcomes of interest. Where possible,
we used WHO-recommended definitions for each of the
three key outcomes (linkage to ART, retention, adher-
ence). Where other outcome measures were used, we
report outcomes as defined by the study’s authors.
We placed no restrictions on countries studied. Only
studies published in English were included.
Search strategy
We searched the Medline (via PubMed), SCOPUS and
Web of Sciences databases following a pre-defined search
strategy included within our published study protocol
registered in the University of York database for Prospec-
tively Registered Systematic Reviews in Health and Social
Care (PROSPERO) [15]. Search terms and full search
strategies are shown in Figure S1. We also searched the
online databases of conferences abstracts from the Inter-
national AIDS Conferences (2006–2014) and the Interna-
tional Conference on AIDS and STDs in Africa (Dates
2008–2013). The bibliographies of selected studies were
reviewed by hand to identify studies that may have been
missed by our search strategy.
Selection of studies
After exclusion of duplicate studies, two reviewers (PM
and CM) independently screened the title and abstracts
of all retrieved studies to identify studies eligible for full
text review. Discrepancies were resolved by discussion
between the reviewers, with arbitration by a third
reviewer (DR) where agreement could not be reached.
A data extraction form, which had been pilot tested on
a sample of manuscripts, was completed independently
by two reviewers (PM and CM) for all studies selected
for full text review. Reviewers recorded the presence of
inclusion or exclusion factors, and if the study was eligi-
ble for inclusion, the following information was recorded
from each study: year of study; study setting and popula-
tion; description of study design and intervention(s)
investigated; and outcome measures assessed. For each
study with data available, the proportion (and 95% con-
fidence interval [CI]) of adolescents completing steps on
the HIV care pathway, retained on ART and adherent to
ART, were recorded. Where these data were not avail-
able, study-reported outcomes were extracted. Where a
control or comparison group was evaluated, the relative
and absolute effect of the intervention and 95% CIs were
recorded, where available. If duplicate or partially dupli-
cated results were presented in more than one study, we
extracted data from both studies and included only the
study with the most complete data.
Two reviewers (PM and CM) undertook an assessment
of methodological quality for each study. For randomised
controlled trials, the Cochrane Collaboration’s Tool for
Assessing Risk of Bias was used [16]. For non-randomised
studies, a modified version of the Newcastle–Ottawa Scale
was used [17]. The Newcastle–Ottawa Scale was modified
by removing items relating to procedures for selection of
the non-exposed cohort, as most studies did not include a
control group. Given the possibility of highly heteroge-
neous study designs, an additional item was added to
assess the presence any other potential sources of bias such
as the size of the study and reported fidelity to study inter-
ventions. Results were compared and a consensus overall
risk of bias judgement was made for each study. Rando-
mised studies were graded as providing good (score 5–6),
moderate (score 3–4) or low quality of evidence (0–2).
Non-randomised studies were graded as providing good
(score 7–10), moderate (score 4–6) or low quality of evi-
dence (score 0–3). An overall judgement of ‘unclear risk of
bias’ was made where there was inadequate information
provided by the study report.
Because we anticipated that studies would come from a
wide variety of settings and populations, and report on a
range of different interventions, we expected that there
would be a high degree of heterogeneity. We therefore
did not plan to attempt to estimate summary measures of
effectiveness for interventions, but would have done so if
the review indicated this to be appropriate.
© 2015 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd. 1017
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Results
Study characteristics
The search identified 3138 unique abstracts, from which
3070 were excluded after review of title and abstract
(Figure S2). Seventy-four manuscripts were reviewed in
full, of which 11 studies met the review’s inclusion crite-
ria [18–28]. The main reason for exclusion was age (41/
63, 65% of exclusions), with studies including a majority
of participants aged <10 years old or >19 years old, and
not reporting age-disaggregated data to allow extraction
data for all or part of the 10- to 19-year age group
(Table S2 – reasons for exclusion).
Characteristics of the 11 included studies are summar-
ised in Table S1. Studies were conducted between 1998
and 2012. Six studies were from the USA [18, 20, 23,
26–28], one from each of the UK [21], France [22], South
Africa [19] and Thailand [24], and one study was a mul-
ticentre study conducted in Kenya, Mozambique,
Rwanda and Tanzania [25]. Three studies were rando-
mised controlled trials [18, 19, 26], and eight were non-
randomised studies with a variety of study designs,
including prospective [21, 22, 24] and retrospective
cohort studies [20, 23], and reports of routinely collected
programme data [25, 27, 28].
The number of participants included in studies ranged
between 9 [23] and 57 038 [25]. The proportion of
adolescent study participants that were male ranged
between 25% [21] and 60% [20]. There was consider-
able variation between studies in definitions of ‘adoles-
cence’, ‘youth’ and ‘young adult’. Three studies
specifically included key populations, including men
who have sex with men [20, 28] and injecting drug
users [20, 26].
Study settings comprised HIV care clinics (n = 9 stud-
ies [18–22, 24–27], two of which described clinics as
being specialist or dedicated adolescent centres [18, 21]),
a children’s hospital [23], and an inpatient rehabilitation
facility for children and adolescents affected by HIV [28].
Two distinct groups of study participants were included
in the different studies: some only included HIV-infected
adolescents meeting defined criteria for treatment failure
or suboptimal adherence [21, 23, 24, 26–28], whilst oth-
ers included HIV-infected adolescents, selected irrespec-
tive of treatment success/failure or adherence [18–20, 22,
25].
In the eleven studies included in the review, a total of
eight interventions were evaluated. We classified interven-
tions as having been applied at the individual-, commu-
nity-, provider and health facility-, and policy and health
system levels (Figure 2).
Interventions applied at the individual level (education
and counselling, directly observed therapy, adherence
support devices and financial incentives) and community
level (peer support) tended to be intensive, applied in
multiple sessions over weeks to months, and were person-
ally tailored to be responsive to the needs of individual
adolescents. In contrast, interventions applied at the pro-
vider and health facility-level (adolescent/youth friendly
clinic opening hours, provision of adolescent-specific ser-
vices) and policy and health system level (decentralisa-
tion) emphasised individual patient needs less, but had
greater potential to reach a larger number of adolescents
and used fewer resources than individual-level
approaches.
Linkage to HIV care and ART
Only one study evaluated interventions to improve ado-
lescents’ linkage to HIV care and ART [25] (Table 1a).
Routinely collected clinic and patient data from a multi-
site study in four countries in sub-Saharan Africa were
used to evaluate the effect of availability of clinic inter-
ventions on pre-ART attrition. At the clinic-level, two
sets of interventions were either available or not avail-
able: adolescent-targeted services (defined as clinics that
had dedicated adolescent clinics and opening hours, peer
educators, or support groups) and services likely to be
used by youth (clinics with screening for sexually trans-
mitted infections, provision of condoms and hormonal
contraceptives, and education). In adjusted analysis, none
of the available clinic adolescent-targeted services likely
to be used by youth were associated with risk of pre-ART
attrition.
Retention on ART
Two studies [20, 25] investigated the effect of interven-
tions to improve adolescents’ retention on ART
(Table 1b). Interventions evaluated included a multidisci-
plinary adolescent clinic staffed by adolescent physicians,
care managers and social workers [20]; decentralisation
of care (defined by authors to be no provision of specific
adolescent-targeted services) [20]; peer support groups
[20, 25]; and adolescent-specific clinic opening hours [20,
25].
In an ecological study in one US HIV clinic, adoles-
cents who had access to multidisciplinary adolescent clin-
ics with individualised support were significantly less
likely to have gaps in care compared to adolescents trea-
ted when these services were not available [20]. Surpris-
ingly, in evaluation of programmatic data from four
sub-Saharan countries [25], the cumulative incidence of
1018 © 2015 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.
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attrition from ART 1 year after starting treatment was
significantly higher amongst clinic attenders where ado-
lescent-specific clinic opening hours were available. Avail-
ability of peer support groups was associated with lower
risk of attrition from ART in univariate analysis, but was
not examined in adjusted models [25].
Adherence to ART
In total, five interventions to improve adolescents’ adher-
ence to ART were evaluated, including counselling and
education; use of adherence support devices; financial
incentives; peer support; and directly observed therapy
(Table 1c).
Seven studies evaluated counselling and education
interventions [18, 19, 21, 22, 24, 26, 27]. Counselling
and education were offered to adolescents and their
carers by clinic staff and researchers in a variety of ways,
including as individuals sessions with a single counsellor
[18]; family sessions with a single counsellor [21]; multi-
disciplinary sessions with an adolescent and/or their ca-
rers [19, 26, 27]; and group counselling sessions [22, 24].
Some studies used established counselling curricula used
in previous studies such as multisystemic therapy [26]
and motivational interviewing [21], whilst others used
open-ended and bespoke counselling and education tech-
niques [18, 19, 22, 24, 27].
In studies of counselling and education, although par-
ticipant groups, settings and content of interventions var-
ied considerably, there was some evidence of
effectiveness, although caution is required due to small
study sizes and methodological issues. In a non-rando-
mised study conducted amongst adolescents attending
two HIV clinics in Roi-Et Province in Thailand, adoles-
cents who received group counselling aimed at improving
empowerment had greater improvements in ART adher-
ence compared to adolescents who did not receive group
counselling [24]. Adolescents with adherence difficulties
attending an urban clinic in the USA who participated in
12-week multidisciplinary family counselling sessions
showed substantial reductions in missed ART doses at
the end of the programme [27].
Peer counselling (group counselling sessions where ado-
lescents patients provided motivation and support to
each, often facilitated by a clinic staff member or
researcher) was investigated in one study of
adolescents attending a hospital outpatient clinic in
France [22]. Groups were not randomly allocated to
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receive peer support or control interventions and numbers
were small. After 2 years of follow-up, the proportion of
participants achieving viral suppression was higher
amongst adolescents who received peer counselling.
In a study from a UK specialist centre, variable
amounts of financial incentives linked to achievement of
HIV viral load results were offered to adolescents with
complex ART histories and previous multiple treatment
interruptions [21]. Results were promising, but limited by
small numbers and lack of comparison groups.
In two studies, adherence support devices (for example,
medication boxes and beepers) were provided to individ-
uals as part of packages of interventions, including edu-
cational and counselling [18], or motivational
interviewing and financial incentives [21]. It is therefore
difficult to distinguish the effects of adherence support
devices from other interventions provided.
Two studies evaluated inpatient directly observed ther-
apy (DOT) provided to adolescents with previous adher-
ence difficulties or virological failure [23, 28]. Both
studies had small numbers of participants, and although
participants’ rates of virological failure showed improve-
ments in the short term (by the end of completion of
DOT), results were not sustained at 6 months after com-
pleting DOT.
Quality and risk of bias assessment
The methodological quality of included studies was
assessed as weak (summarised in Table 2 and reported in
detail for each study in Table S3). All three of the
included randomised controlled trials had methodological
and reporting factors that meant they were classified as
being at low methodological quality. Notably, none of
the trials completely followed the CONSORT statement
guidelines for reporting randomised controlled trials. Par-
ticular concerns were noted with procedures for randomi-
sation and allocation (either at high risk of bias or not
reported) [18, 19, 26], protocol-driven consistency in
application of interventions to participants [18, 19, 26]
and selective reporting of outcomes [19, 26].
None of the randomised controlled trials reported cal-
culations to determine optimal sample sizes for detection
of effects, and all three sample sizes were small, ranging
from 34 [26] to 65 [19] randomised participants. The rel-
ative or absolute effects of interventions were only
reported by one randomised controlled trial [26], and no
trials reported confidence intervals around effect esti-
mates, with studies instead usually reporting only P-val-
ues for between-group comparisons. The possible effects
of confounding variables were not adequately considered
in any of the randomised controlled trials identified by
the review. Handling of missing exposure and outcome
data was also problematic in two studies [19, 26].
Of the eight non-randomised studies included, three
studies were assessed as being of good methodological
quality [20, 21, 25], four studies were of moderate qual-
ity [23, 24, 27, 28], and one was of low quality [22].
Common methodological problems included small sample
sizes [20–24, 27, 28]; inconsistency in application of
interventions to participants [20, 28]; failure to identify
and appropriately adjust for potential confounding vari-
ables [20–24, 27, 28]; lack of comparison groups [20,
21, 23, 27, 28]; and selective outcome reporting [20, 22,
23]. In the studies reporting on interventions to improve
adolescents’ adherence to ART, particular concerns
included the use of non-standard and non-validated mea-
sures of adherence.
Discussion
The main findings from this systematic review were that,
despite having worse HIV care outcomes than other age
groups [1], few studies that have evaluated interventions
to support adolescents’ linkage, retention and adherence
to ART have been reported. As we move towards an era
of universal treatment for HIV [10], the clinical and pub-
lic health benefits of widening access to ART for adoles-
cents will not be realised until cost-effective and
sustainable service delivery interventions are widely
implemented. The current evidence base from research on
how best to do this is very weak. Although there are
hints that some interventions may be effective, there is an
urgent need for more rigorous, and larger, studies to clar-
ify the effectiveness and replicability of potentially
encouraging interventions.
We identified only 11 studies over a period of 13 and a
half years, emphasising that the particular needs of ado-
lescents living with HIV have not been widely studied
[5]. Moreover, the majority of studies were conducted in
the USA (n = 6) or Europe (n = 2), with only three stud-
ies conducted in countries with generalised HIV epidem-
ics, where the majority of the world’s adolescents live.
Most of the reports were of very small studies, with 8 of
the 11 studies including fewer than 50 participants. The
three randomised controlled trials were all small, with 34
[26], 37 [18] and 65 [19] participants, respectively. The
only two studies with over 100 participants were based
on a retrospective cohort study in USA with a total of
174 participants over the three eras of care that were
compared [20], and a very large multicountry study that
used routinely reported clinic data [25].
The service delivery interventions that were identified
in this review were predominantly focused on relatively
© 2015 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd. 1025
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resource-intensive approaches applied at the individual
level, such as motivational interviewing [26], counselling
and peer support [19, 22, 24, 27], education [19],
directly observed therapy [23, 28] and financial incentives
[21]. This likely reflects attempts to overcome the psycho-
logical, behavioural and educational difficulties experi-
enced by adolescents (which may be contributory to poor
outcomes) [29]. However, interventions targeted at this
level alone are unlikely to be generalisable or sufficient to
overcome the considerable structural and health system
barriers faced by adolescents. Complementary interven-
tions, acting at different levels, are likely to be required.
A recent systematic review of interventions to improve
linkage from HIV diagnosis to initiation of ART amongst
all HIV-infected people in low- and middle-income coun-
tries similarly identified a small number of studies, with
most judged to be of poor quality, and the authors noted
that few of the studies evaluated interventions specifically
targeted to adolescents [30].
In contrast to the situation for adolescents, a greater
number of interventions to improve adults’ linkage, reten-
tion and adherence to ART have been evaluated and have
been introduced into routine clinical practice, especially
in resource-limited settings [30, 31]. At the policy and
health systems levels, task-shifting to lower cadres of
health workers and non-medical personal, decentralising
care to primary care level and home delivery of HIV care
including ART initiation has increased retention in care
and improved acceptability [32], whilst decentralising
care to primary care level has improved accessibility [33].
Home initiation and delivery of HIV care have been
shown to be effective in improving linkage and retention
in care in well-powered cluster-randomised controlled tri-
als [34, 35]. Integration of HIV care services into general
medical clinics has been widely implemented [36]. At first
glance, such interventions seem to be promising
approaches that could be offered to adolescents. How-
ever, adolescents may have substantially different clinical,
social and emotional needs than adults and unmodified
implementation of interventions that have been designed
for adults may not be appropriate. One example of an
adolescent-tailored intervention identified in this review
was ‘adolescent-friendly’ clinics, with special opening
hours for adolescents and targeted services [25]. How-
ever, limitations in the study’s application of interven-
tions and lack of clear evidence of effectiveness preclude
recommendation of this strategy until further high-quality
studies are conducted.
This study had important strengths, including the
comprehensive search strategy, rigorous methods and
wide scope covering all aspects of the HIV care path-
way for adolescents who had been diagnosed with
HIV. However, there were limitations. Of principal
concern was the apparent low-to-moderate quality of
the majority of studies, meaning that any policy recom-
mendations for implementation must be made with
extreme caution until further, high-quality studies have
been conducted and adequately reported. Age defini-
tions of adolescence varied widely between studies, and
some studies that included adolescent participants were
excluded because the majority of participants were not
aged between 10 and 19 years, or we were unable to
extract data for this age group [37–76]. In informal
review of these studies, most of the interventions
assessed were broadly similar to those included in the
review and also had low methodological and/or report-
ing quality.
Because of the wide scope of the study and large num-
bers of possible study types included, it is possible that a
small number of studies were inadvertently excluded
because of our search or inclusion criteria. For example,
due to time and logistic constraints, we only included
studies published in English. This may partly explain the
lack of studies from Latin America. In accordance with
our published study protocol, we did not attempt to esti-
mate summary measures of effectiveness for interventions
due to the high degree of heterogeneity in the interven-
tions identified.
Conclusions and recommendations
Over a period of 13.5 years, only 11 studies examining
the effect of interventions on adolescents’ linkage, reten-
tion or adherence to ART were identified, with most
studies conducted in high-income countries and using rel-
atively resource-intensive, individual client approaches.
Overall, the methodological quality of the reports of the
identified studies was poor, and most studies had very
few participants. Although qualified by the poor quality
of studies, some approaches appear promising and need
to be evaluated in larger, rigorous studies. These
approaches, along with those identified in studies that
had a combination of adults and adolescents [30, 32, 33,
77, 78], are summarised in Box 1.
Adolescents living with HIV are currently a neglected
group. To ensure they are able to achieve the benefits of
ART, rigorous evaluation of a wider range of existing
and innovative service delivery interventions applied at
the individual, health facility and policy levels are
urgently required. When designing interventions, studies
need to be cognisant of the limited resources available
within health systems, which are particularly constrained
in the countries with generalised HIV epidemics and large
numbers of HIV-infected adolescents.
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